Paying user area
Try for free
CVS Health Corp. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Reportable Segments
- Capital Asset Pricing Model (CAPM)
- Operating Profit Margin since 2005
- Price to Sales (P/S) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to CVS Health Corp. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss) attributable to CVS Health common shareholders1 (in millions) | ÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 12, 2025 | = | ÷ | = | ÷ | |||||||
Feb 7, 2024 | = | ÷ | = | ÷ | |||||||
Feb 8, 2023 | = | ÷ | = | ÷ | |||||||
Feb 9, 2022 | = | ÷ | = | ÷ | |||||||
Feb 16, 2021 | = | ÷ | = | ÷ | |||||||
Feb 18, 2020 | = | ÷ | = | ÷ | |||||||
Feb 28, 2019 | = | ÷ | = | ÷ | |||||||
Feb 14, 2018 | = | ÷ | = | ÷ | |||||||
Feb 9, 2017 | = | ÷ | = | ÷ | |||||||
Feb 9, 2016 | = | ÷ | = | ÷ | |||||||
Feb 10, 2015 | = | ÷ | = | ÷ | |||||||
Feb 11, 2014 | = | ÷ | = | ÷ | |||||||
Feb 15, 2013 | = | ÷ | = | ÷ | |||||||
Feb 17, 2012 | = | ÷ | = | ÷ | |||||||
Feb 18, 2011 | = | ÷ | = | ÷ | |||||||
Feb 26, 2010 | = | ÷ | = | ÷ | |||||||
Feb 27, 2009 | = | ÷ | = | ÷ | |||||||
Feb 27, 2008 | = | ÷ | = | ÷ | |||||||
Feb 27, 2007 | = | ÷ | = | ÷ | |||||||
Mar 14, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of CVS Health Corp. Annual Report.
- Share Price
- The share price demonstrated a fluctuating trend over the analyzed period. Initially, the price increased from $30.57 in March 2006 to a peak of $101.68 in February 2015. Following this peak, a general declining trend is noted, falling to $63.22 by February 2025. Notably, there was a significant rise from $33.06 in February 2011 to $101.68 in February 2015, followed by volatility and a downward movement overall in the subsequent years.
- Earnings Per Share (EPS)
- EPS showed a consistent upward trend from $1.48 in 2006, reaching a peak of $6.53 in February 2018. An irregular decrease is observed in 2019 with a negative EPS of -$0.46, indicating a loss during that year. However, the EPS recovered in the following years, with fluctuations seen thereafter, ending at $3.66 in 2025. This suggests overall growth in profitability with some volatility and a notable one-year setback.
- Price to Earnings Ratio (P/E)
- The P/E ratio generally declined from a high of 22.10 in 2008 to a low of around 10.69 in 2018, indicating potential undervaluation or improved earnings. The ratio then increased again, surpassing 27 in 2023, pointing to higher market valuation relative to earnings or decreased earnings growth expectations. After 2023, the ratio dropped again to 17.28 in 2025. The missing P/E value for 2019 coincides with the negative EPS, which likely prevents calculation.
- Overall Insights
- The company experienced substantial growth in both share price and earnings per share from 2006 through 2015, indicating successful business expansion or improved market perception. The peak in share price lagged behind EPS peaks, implying market expectations adjustment. The negative EPS in 2019 marks an anomaly that adversely affected valuation metrics such as P/E ratio. Post-2019, performance showed recovery but with increased volatility in both market price and earnings. The shifts in P/E ratio reflect changing investor sentiment on future profitability and perceived risks over the period.
Comparison to Competitors
CVS Health Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|
Feb 12, 2025 | ||||||
Feb 7, 2024 | ||||||
Feb 8, 2023 | ||||||
Feb 9, 2022 | ||||||
Feb 16, 2021 | ||||||
Feb 18, 2020 | ||||||
Feb 28, 2019 | ||||||
Feb 14, 2018 | ||||||
Feb 9, 2017 | ||||||
Feb 9, 2016 | ||||||
Feb 10, 2015 | ||||||
Feb 11, 2014 | ||||||
Feb 15, 2013 | ||||||
Feb 17, 2012 | ||||||
Feb 18, 2011 | ||||||
Feb 26, 2010 | ||||||
Feb 27, 2009 | ||||||
Feb 27, 2008 | ||||||
Feb 27, 2007 | ||||||
Mar 14, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
CVS Health Corp. | Health Care Equipment & Services | |
---|---|---|
Feb 12, 2025 | ||
Feb 7, 2024 | ||
Feb 8, 2023 | ||
Feb 9, 2022 | ||
Feb 16, 2021 | ||
Feb 18, 2020 | ||
Feb 28, 2019 | ||
Feb 14, 2018 | ||
Feb 9, 2017 | ||
Feb 9, 2016 | ||
Feb 10, 2015 | ||
Feb 11, 2014 | ||
Feb 15, 2013 | ||
Feb 17, 2012 | ||
Feb 18, 2011 | ||
Feb 26, 2010 | ||
Feb 27, 2009 | ||
Feb 27, 2008 | ||
Feb 27, 2007 | ||
Mar 14, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
CVS Health Corp. | Health Care | |
---|---|---|
Feb 12, 2025 | ||
Feb 7, 2024 | ||
Feb 8, 2023 | ||
Feb 9, 2022 | ||
Feb 16, 2021 | ||
Feb 18, 2020 | ||
Feb 28, 2019 | ||
Feb 14, 2018 | ||
Feb 9, 2017 | ||
Feb 9, 2016 | ||
Feb 10, 2015 | ||
Feb 11, 2014 | ||
Feb 15, 2013 | ||
Feb 17, 2012 | ||
Feb 18, 2011 | ||
Feb 26, 2010 | ||
Feb 27, 2009 | ||
Feb 27, 2008 | ||
Feb 27, 2007 | ||
Mar 14, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-29), 10-K (reporting date: 2006-12-30), 10-K (reporting date: 2005-12-31).